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Summary. Background: Clinical and experimental 
observations suggest that more than one pathway might 
be involved in the development of metastases. In the 
present study, we examined the presence of tumor DNA 
in plasma using an experimental model in which tumor 
cells were modified with a genome-associated tag. We 
also investigated whether plasma of tumor-bearing rats 
had any effect on cultured cells and healthy animals. 
Methods: Transfected cancer cells (DHDlK12-PROb 
stably transfected with pCDNA3.1CAT.) were injected 
subcutaneously into the chest of BD-IX rats. Animals 
were divided into ten groups according to the time 
between injection of tumor cells and euthanasia. Prior to 
euthanasia (2-14 week), blood samples were collected by 
cardiac puncture. To detect circulating tumor cells and 
CAT-encoding DNA in plasma, we performed PCR with 
nested primers. Fifty samples of plasma were chosen at 
random to supplement the medium of fifty cultures of 
DHD cells for 10-12 days. PCR for the detection of CAT 
DNA in cells was performed approximately one to two 
months later. Four healthy rats  received an 
intraperitoneal injection of plasma from a tumor-bearing 
rat five times at week for 4 to 6 weeks. Animals were 
sacrificed and samples of liver, kidney, spleen, 
omentum, blood and lung were processed by PCR for 
the detection of CAT DNA. Results: Detection of CAT 
DNA in plasma was slightly more frequent than in the 
buffy-coat fraction. All surviving cultures that had been 
supplemented with plasma were positive at some point 
for CAT DNA. In all four healthy animals injected with 
plasma of tumor-bearing rats, the marker gene for CAT 
was found in extracts of lungs. Conclusion: Our present 
observation lead us to propose the following hypothesis. 
Metastases might develop as a result of transfection of 
susceptible cells in distant target organs with dominant 
oncogenes that are present in the circulating plasma and 
are derived from the primary tumor. 
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Introduction 
Most patients with cancer die as a consequence of 
metastases. It is widely assumed that such metastases 
arise from seeding of cancer cells from the primary 
tumor (Mellado et al., 1996). The exact relationship 
between circulating tumor cells and the development of 
metastases in specific target organs is unclear. Nonethe- 
less, we do know that the implantation of tumor cells 
from the peripheral blood is an inefficient process 
because fewer than 0.1% of circulating tumor cells 
survive in the circulation (Glavies et al., 1988). 
Moreover, only few cases have been reported in which 
tumor cells could be identified in the blood of patients 
with cancer by sensitive techniques based on the 
polymerase chain reaction (PCR; Jonas et al., 1996; 
Mori et al., 1996; Nakamori et al., 1997; Wong et al., 
1997; Garcia-Olmo et al., 1999a). 
To our knowledge, most PCR-based studies that 
have focused on the dissemination of tumor cells via the 
blood of cancer patients have used the cellular fraction 
of the blood as the source of DNA for amplification by 
PCR. However, the results of several recent studies 
indicate that tumor DNA can also be detected in the 
plasma or serum (Mulcahy et al., 1996; Anker et al., 
1997; De Kok et al., 1997; Kopreski et al., 1997). 
The detection of free, circulating tumor DNA in the 
plasma of cancer patients opens up new possibilities for 
the diagnosis of cancer and prognosis. Most successful 
studies have been performed using PCR and primers that 
are specific for different mutations in the K-ras onco- 
gene (Anker et al., 1997; De Kok et al., 1997; Kopreski 
et al., 1997). However, it is unknown whether mutant K- 
ras DNA in the plasma represents extracellular DNA 
released from a tumor, DNA released from necrotic or 
apoptotic cells or DNA released as a result of the lysis 
of fragile, circulating cancer cells. Whatever the 
mechanism for their presence might be, it is now clear 
that oncogenes can circulate in the plasma fraction of the 
blood, and we can now ask whether this phenomenon 
has potentially important implications in cancer patients. 
We have developed an experimental model of cancer 
using cells with a genome-associated tag (Garcia-Olmo 
et al., 1999b). In our model, tumors are transplanted in 














